Evaluating the Clinical Efficacy of Zoledronic Acid in the Prevention and Treatment of Osteoporosis in Postmenopausal Women, Compared with Conventional Medications

Evaluating the Clinical Efficacy of Zoledronic Acid in the Prevention and Treatment of Osteoporosis in Postmenopausal Women, Compared with Conventional Medications

Background: Due to the development of drugs, regarding this matter that customers of health services are unable to assess the clinical and financial aspects of medical technologies, evaluating the clinical efficacy of drugs is very important. This study aimed to evaluate the clinical efficacy of zol...

Full description

Bibliographic Details
Main Authors:	Fatemeh Rostami-Golmohammadi, Ali Akbari-Sari, Shekoufeh Nikfar, Mahnaz Abbasi, Batoul Ahmadi, Ali Kazemi-Kariani
Format:	Article
Language:	fas
Published:	Isfahan University of Medical Sciences 2015-02-01
Series:	مجله دانشکده پزشکی اصفهان
Subjects:	Clinical effectiveness Zoledronic acid Osteoporosis Menopause
Online Access:	http://jims.mui.ac.ir/index.php/jims/article/view/3294

Similar Items

Cost-Effectiveness of Zoledronic Acid to Prevent and Treat Postmenopausal Osteoporosis in Comparison with Routine Medical Treatment
by: Fateme Rostami Golmohamdi, et al.
Published: (2016-12-01)

Role of zoledronic acid in the prevention and treatment of osteoporosis
by: Räkel A, et al.
Published: (2011-03-01)

IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
by: Lin H, et al.
Published: (2021-07-01)

Management of osteoporosis in the aging male: Focus on zoledronic acid
by: Paul K Piper Jr, et al.
Published: (2009-06-01)

Potential protective effect of zoledronic acid when switching from long-term therapy of osteoporosis with denosumab
by: O. V. Yakushevskaya
Published: (2021-01-01)

Intravenous zoledronate for postmenopausal women with osteopenia and osteoporosis: a systematic review and metanalysis
by: Fernanda Martins Gazoni, et al.
Published: (2023-05-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-06-01)

Annual zoledronic acid for the treatment of osteoporosis: A randomized controlled trial
by: Asif Hussain, et al.
Published: (2023-01-01)

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients
by: Jun Xie, et al.
Published: (2019-12-01)

Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients
by: Huang CF, et al.
Published: (2021-08-01)

How zoledronic acid improves osteoporosis by acting on osteoclasts
by: Biao Wang, et al.
Published: (2022-08-01)

Role of zoledronic acid in treatment of osteoporosis and prevention of fractures
by: A. V. Krivova, et al.
Published: (2022-01-01)

Zoledronic acid induced unilateral anterior uveitis
by: Shipra Gupta, et al.
Published: (2020-01-01)

Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis
by: Masashi Uehara, et al.
Published: (2021-11-01)

Intravenous bisphosphonates for postmenopausal osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

Intravenous Bisphosphonates for Postmenopausal Osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
by: Ruxu You, et al.
Published: (2022-03-01)

Two-year effectiveness of zoledronic acid with or without eldecalcitol in Japanese patients with osteoporosis: A randomized prospective study
by: Takeshi Mochizuki, et al.
Published: (2022-06-01)

Botanicals in Postmenopausal Osteoporosis
by: Wojciech Słupski, et al.
Published: (2021-05-01)

Intravenous Zoledronate 4 mg for the treatment of post-menopausal osteoporosis: A prospective open-labeled study
by: Thunyawarin Arunthanachaikul, et al.
Published: (2022-06-01)

Drug-Inclusive Inorganic–Organic Hybrid Systems for the Controlled Release of the Osteoporosis Drug Zoledronate
by: Maria Vassaki, et al.
Published: (2022-09-01)

The Use of Intravenous Zoledronate May Reduce Retear Rate after Rotator Cuff Repair in Older Female Patients with Osteoporosis: A First In-Human Prospective Study
by: Jae-Hoo Lee, et al.
Published: (2022-02-01)

Once-yearly zoledronic acid in hip fracture prevention
by: Oddom Demontiero, et al.
Published: (2009-03-01)

Prediction of musculoskeletal pain after the first intravenous zoledronic acid injection in patients with primary osteoporosis: development and evaluation of a new nomogram
by: Xiaoxia Zheng, et al.
Published: (2023-10-01)

The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients
by: Wang Z, et al.
Published: (2021-10-01)

Evaluation of Patient Satisfaction, Preference and Side Effects after Annual Zoledronic Acid Infusion in Patients with Osteoporosis
by: Banu Dilek, et al.
Published: (2017-04-01)

Identifying therapeutic biomarkers of zoledronic acid by metabolomics
by: Xiang Li, et al.
Published: (2023-04-01)

Case Report: Acute Unilateral Uveitis Induced by Infusion of Zoledronic Acid
by: Kadir Songür, et al.
Published: (2022-08-01)

The Effect of Education Based on Health Belief Model on Preventive Factors of Osteoporosis among Postmenopausal Women
by: Leila Torshizi, et al.
Published: (2009-08-01)

Evaluation of the tolerability of zoledronic acid preparations for parenteral administration
by: I. A. Shafieva, et al.
Published: (2022-07-01)

Hormone replacement therapy and the prevention of postmenopausal osteoporosis
by: Marco Gambacciani, et al.
Published: (2014-09-01)

Oestradiol Contributes to Differential Antitumour Effects of Adjuvant Zoledronic Acid Observed Between Pre- and Post-Menopausal Women
by: Victor G. Canuas-Landero, et al.
Published: (2021-10-01)

Postmenopausal osteoporosis: Our experience
by: R N Mehrotra, et al.
Published: (2012-01-01)

Preventable risk factors for osteoporosis in postmenopausal women: Systematic review and meta-analysis
by: Jyoti Thulkar, et al.
Published: (2016-01-01)

ZOLEDRONIC ACID ADMINISTRATION ENHANCES FRACTURE HEALING IN THE OSTEOPOROTIC FRACTURES IN OVARIECTOMIZED RABBITS
by: Cansabuncu Gokhan, et al.
Published: (2019-05-01)

Comparison of the Efficacy of Zoledronate and Denosumab in Patients with Acute Osteoporotic Vertebral Compression Fractures: A Randomized Controlled Trial
by: Seong Son, et al.
Published: (2024-04-01)

Brazilian guidelines for the diagnosis and treatment of postmenopausal osteoporosis
by: Sebastião Cézar Radominski, et al.

Epidemiology of osteoporosis in postmenopausal women aged 47 to 60 years
by: Meiyanti Meiyanti
Published: (2016-02-01)

Epidemiology of osteoporosis in postmenopausal women aged 47 to 60 years
by: Meiyanti
Published: (2010-12-01)

Nutritional education in the primary prevention of osteoporosis in perimenopausal and postmenopausal women
by: Joanna Woźniak-Holecka, et al.
Published: (2014-03-01)